Advair Diskus Information
What's inside Advair Diskus
Advair Diskus Active Ingredients: fluticasone propionate, salmeterol xinafoate, details.| Advair Diskus Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Advair Diskus 500 mcg-50 mcg | powder | inhalation | 1.0 inhalation | OTC |
| Advair Diskus 500 mcg-50 mcg | powder | inhalation | 1.0 inhalation | OTC |
| Advair Diskus 250 mcg-50 mcg | powder | inhalation | 1.0 inhalation | OTC |
| Advair Diskus 100 mcg-50 mcg | powder | inhalation | 1.0 inhalation | OTC |
Recent Advair Diskus Side Effects
Posted by regular_exerciser 1 day ago
I've had all these same symptoms at one point during the two years I've been taking Advair. I've had exercise induced asthma ...
Posted by sacisi 5 days ago
Well it is 5:02 am and thanks to Advair I am still wide awake.
So here goes my experience of taking only two (2) doses of ad...
Posted by propsguy 17 days ago
i've been taking the 100/50 advair for years now. i have only ever taken one dose a day, frankly out of cheapness. i was un...
Advair Diskus in the News
Glaxo's Advair Lowers Death Risk in Smoker's Cough (Update1) - Bloomberg
28 (Bloomberg) -- GlaxoSmithKline Plc's Advair Diskus inhaler cut the risk of death in people with a lung condition caused by smoking more than Boehringer ...
Fri Dec 28 03:54:26 -0500 2007
Glaxo's Advair Lowers Death Risk in Smoker's Cough (Update2) - Bloomberg
all 60 news articles
Fri Dec 28 06:07:57 -0500 2007
Pearl Therapeutics, Inc. Expands Its Senior Management Team With ... - SunHerald.com
Dr. Reisner played a diverse and integral role in the development of several key products including Advair(R) Diskus(R) and Serevent(R) Diskus(R) for COPD, ...
Thu Dec 20 08:44:59 -0500 2007
Advair Diskus Chemical Information
fluticasone propionate - The propionate salt form of fluticasone, a synthetic trifluorinated glucocorticoid receptor agonist with antiallergic, antiinflammatory and antipruritic effects. Binding and activation of the glucocorticoid receptor results in the activation of lipocortin that in turn inhibits cytosolic phospholipase A2, which triggers cascade of reactions involved in synthesis of inflammatory mediators, such as prostaglandins and leukotrienes. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production.
salmeterol xinafoate
Advair Diskus RSS Feed